Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

US Patent 10322113 · Granted Jun 18, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2025
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2025
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast c2019
Intravenous formulation and LC/MS/MS analysis method for GMC12018
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2017
Small cationic antimicrobial peptides2017
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2016
Small cationic antimicrobial peptides2015